Search results

...] for quantitation of tumor-infiltrating lymphocytes (TILs) allow, for the first time, the development of personalized cancer immunotherapies that target pa ...can be a major task in itself, as the list of potential applications must first be identified and screened to determine promising candidates before an in-d